Perrigo Finding Balance As Three-Legged Stool With Two Consumer Units, Rx Division
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
As new CEO Uwe Röhrhoff plans a "value creation" analysis, the improving Rx business growth could be essential for company because US competition from smaller, online brands is increasing in the OTC drug space and its sales of its consumer health products in Europe have yet to reach expectations.
You may also be interested in...
Perrigo Taps CEO With Global Operations Expertise At Pharma Packaging Firm
Perrigo named German packaging firm executive Uwe Rohrhoff as CEO, replacing John Hendrickson, effective Jan. 15. The former head of Gerresheimer will bring experience leading a global business that included 36 manufacturing facilities across 14 countries and sales of $1.7bn.
Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo
Amazon introduced Basic Care line of cough, cold, allergy and digestive treatment OTCs developed in a partnership with Perrigo. The range could be a major threat to store brand and private label OTCs, though success may depend on whether consumers wait for Amazon deliveries or shop at stores.